These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 2261877)

  • 1. [Alterations of c-myc and c-Ha-ras-1 oncogenes in human ovarian cancer].
    Serova OM; Nikiforova IF; Iurkova LE; Vinokurov VL; Kniazev PG
    Eksp Onkol; 1990; 12(6):47-9. PubMed ID: 2261877
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Frequency and rearrangements of alleles of proto-oncogene c-Ha-ras-1 and their association with development of various malignant tumors in man].
    Nikiforova IF; Serova OM; Pluzhnikova GF; Kniazev PG; Seĭts IF
    Genetika; 1990 Mar; 26(3):531-40. PubMed ID: 1972367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distribution and rearrangements of alleles of c-Ha-ras-1 protooncogene and their correlation with the development of lung, ovarian and thyroid cancers.
    Knyazev PG; Nikiforova IF; Serova OM; Pluzhnikova GF
    Neoplasma; 1990; 37(6):647-55. PubMed ID: 1980342
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic alterations of c-myc, c-erbB-2, and c-Ha-ras protooncogenes and clinical associations in human breast carcinomas.
    Garcia I; Dietrich PY; Aapro M; Vauthier G; Vadas L; Engel E
    Cancer Res; 1989 Dec; 49(23):6675-9. PubMed ID: 2573420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemical study of oncogene product ras p21, c-myc and growth factor EGF in breast carcinomas.
    Mizukami Y; Nonomura A; Noguchi M; Taniya T; Koyasaki N; Saito Y; Hashimoto T; Matsubara F; Yanaihara N
    Anticancer Res; 1991; 11(4):1485-94. PubMed ID: 1660689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phosphotyrosine, p62 c-myc and p21 c-Ha-ras proteins in colonic epithelium of normal and dimethylhydrazine-treated rats: an immunohistochemical analysis.
    Schwartz B; Benharroch D; Prinsloo I; Cagnano E; Lamprecht SA
    Anticancer Res; 1995; 15(1):211-8. PubMed ID: 7537485
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ras, C-myc and C-erbB-2 oncoprotein expression in non-AIDS Mediterranean Kaposi's sarcoma.
    Spandidos DA; Kaloterakis A; Yiagnisis M; Varatsos A; Field JK
    Anticancer Res; 1990; 10(6):1619-25. PubMed ID: 1980998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heterogeneous immunoreactivity of frozen human benign and malignant breast lesions to C-MYC and C-Ha-ras cellular oncogenes.
    Pechoux C; Chardonnet Y; Chignol MC; Noël P
    Histol Histopathol; 1994 Jan; 9(1):35-44. PubMed ID: 8003818
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amplification of c-myc oncogene and absence of c-Ha-ras point mutation in human bone sarcoma.
    Barrios C; Castresana JS; Ruiz J; Kreicbergs A
    J Orthop Res; 1993 Jul; 11(4):556-63. PubMed ID: 8101872
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Somatic deletions and mutations of c-Ha-ras gene in human cervical cancers.
    Riou G; Barrois M; Sheng ZM; Duvillard P; Lhomme C
    Oncogene; 1988 Sep; 3(3):329-33. PubMed ID: 3060795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Genetic alterations in the genesis and development of ovarian cancer].
    Okamoto A; Yokoyama S; Terashima Y
    Gan To Kagaku Ryoho; 1992 Oct; 19(12):1971-6. PubMed ID: 1358031
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Amplification of proto-oncogenes C-myc, C-N-ras, C-Ki-ras, C-erbB2 in ovarian carcinoma].
    Bian M; Fan Q; Huang S
    Zhonghua Fu Chan Ke Za Zhi; 1995 Jul; 30(7):406-9. PubMed ID: 7587576
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amplifications of proto-oncogenes in ovarian carcinoma.
    Bian M; Fan Q; Huang S; Ma J; Lang J
    Chin Med J (Engl); 1995 Nov; 108(11):844-8. PubMed ID: 8585978
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [c-myc and c-Ha-ras proto-oncogenes in cervical cancer: prognostic value].
    Riou G; Sheng ZM; Zhou D; Lusinchi A; Le Doussal V; Barrois M
    Bull Cancer; 1990; 77(4):341-7. PubMed ID: 2191730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression and amplification of c-myc and c-Ha-ras oncogenes in pleomorphic salivary adenoma.
    Xue H; Situ ZQ; Wang CJ; Wu JZ
    Chin Med J (Engl); 1993 Jan; 106(1):22-5. PubMed ID: 8389270
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic prediction in neuroblastomas: clinical significance of combined analysis for Ha-ras p21 expression and N-myc gene amplification.
    Tanaka T; Seeger RC; Tanabe M; Hiyama E; Shimoda H; Ida N
    Cancer Detect Prev; 1994; 18(4):283-9. PubMed ID: 7982238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential effects by Mad and Max on transformation by cellular and viral oncoproteins.
    Cerni C; Bousset K; Seelos C; Burkhardt H; Henriksson M; Lüscher B
    Oncogene; 1995 Aug; 11(3):587-96. PubMed ID: 7630643
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ontogeny of Ha-ras and c-myc mRNA levels in rabbit embryo and extraembryonic tissues by quantitative in situ hybridization.
    Martinoli MG; Lambert RD; Pothier F; Pelletier G
    Mol Reprod Dev; 1992 Jan; 31(1):1-8. PubMed ID: 1562321
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential regulation of the clusterin gene by Ha-ras and c-myc oncogenes and during apoptosis.
    Klock G; Storch S; Rickert J; Gutacker C; Koch-Brandt C
    J Cell Physiol; 1998 Dec; 177(4):593-605. PubMed ID: 10092212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oncogene patterns in breast and ovarian carcinomas.
    Csókay B; Papp J; Besznyák I; Bösze P; Sárosi Z; Tóth J; Zalay Z; Oláh E
    Eur J Surg Oncol; 1993 Dec; 19(6):593-9. PubMed ID: 7903645
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.